S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ABCL AbCellera Biologics Inc

3.75

-0.0375 (-0.99%)

Last Updated: 09:34:30

Delayed by 15 minutes

AbCellera teams up with EQRx in new innovative medicines

To read the full story on Seeking Alpha, click here.

AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more AbCellera Biologics Charts.

AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more AbCellera Biologics Charts.

AbCellera Biologics Inc News

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
Wednesday 1 May 2024 (1 day ago) • Business Wire

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
Monday 8 April 2024 (3 weeks ago) • Business Wire

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
Wednesday 3 April 2024 (4 weeks ago) • Business Wire

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
Tuesday 19 March 2024 (1 month ago) • Business Wire

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
Monday 11 March 2024 (2 months ago) • Business Wire

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
Tuesday 5 March 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

AbCellera Announces Resignation of Board Member
Friday 23 February 2024 (2 months ago) • Business Wire

AbCellera to Present at Upcoming Investor Conferences in March
Thursday 22 February 2024 (2 months ago) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)

More AbCellera Biologics Inc News Articles

Atacama Resources (PK)

Global Developments (PK)

NaturalShrimp (QB)

Mullen Automotive

Verb Technology

International Star (PK)

Federal Home Loan Mortgage (QB)

FBEC Worldwide (PK)

Moon Equity (PK)

Auto Parts 4Less (PK)

NioCorp Developments

Globestar Therapeutics (PK)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions